hydroxyurea has been researched along with Symptom Cluster in 38 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 38-year-old man with idiopathic hypereosinophilic syndrome had an inadequate response to steroids and severe side effects from hydroxyurea treatment, which necessitated withdrawal of the treatment." | 7.68 | Successful long-term control of idiopathic hypereosinophilic syndrome with etoposide. ( de Vries, EG; Smit, AJ; van Essen, LH, 1991) |
| " After two patients had a rapid increase in WBC counts and clinical signs reminiscent of the 'ATRA syndrome' seen in acute promyelocytic leukemia, with fatal outcome in one of them, it was decided to add hydroxyurea (HY) to ATRA to patients with high WBC at inclusion or during ATRA treatment, and no more cases of ATRA syndrome were seen." | 5.08 | All-trans retinoic acid in adult chronic myelomonocytic leukemia: results of a pilot study. ( Cambier, N; Chomienne, C; Fenaux, P; Guerci, A; Menot, ML; Wattel, E, 1996) |
| " prevention of overwhelming bacterial infection, present indications and controversies regarding blood transfusion, prevention of stroke, acute chest syndrome, hydroxyurea therapy--probably the best disease modifying agent at the moment, stem cell transplantation--a cure and certain promising experimental therapies including gene therapy have been discussed in this review." | 4.82 | Advances in management of sickle cell disease. ( Agarwal, MB, 2003) |
| " We describe the case of a 62-year-old man who developed precursor T-cell (pre-T) ALL 18 months after the diagnosis of an unclassifiable chronic myeloproliferative syndrome (CMPD, U), which had been treated with hydroxyurea (HU) over 12 months." | 3.74 | A case of chronic myeloproliferative syndrome followed by precursor T-cell acute lymphoblastic leukemia. ( Bacher, U; Haferlach, C; Haferlach, T; Harich, HD; Kern, W; Schnittger, S, 2007) |
| "A 38-year-old man with idiopathic hypereosinophilic syndrome had an inadequate response to steroids and severe side effects from hydroxyurea treatment, which necessitated withdrawal of the treatment." | 3.68 | Successful long-term control of idiopathic hypereosinophilic syndrome with etoposide. ( de Vries, EG; Smit, AJ; van Essen, LH, 1991) |
| "Sudden sensorineural hearing loss that presents as the initial sign of haematological disease is very rare." | 2.41 | Sudden hearing loss in chronic myelogenous leukaemia implicating the hyperviscosity syndrome. ( Chae, SW; Cho, JH; Hwang, SJ; Kang, HJ; Lee, JH, 2002) |
| "Some sickle cell anemia (SCA) patients suffer significantly worse phenotypes than others." | 1.40 | Mast cell activation syndrome as a significant comorbidity in sickle cell disease. ( Afrin, LB, 2014) |
| "Treatment with hydroxyurea was followed by a dramatic response of both the polycythemia vera and the HES, with return to normal of the abnormal immunologic measures." | 1.27 | Hypereosinophilic syndrome associated with polycythemia vera. ( Berrebi, A; Varon, D; Wetzler, M, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (39.47) | 18.7374 |
| 1990's | 11 (28.95) | 18.2507 |
| 2000's | 8 (21.05) | 29.6817 |
| 2010's | 2 (5.26) | 24.3611 |
| 2020's | 2 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, J | 1 |
| Hou, D | 1 |
| Annis, J | 1 |
| Sargolzaeiaval, F | 1 |
| Appelbaum, J | 1 |
| Takahashi, E | 1 |
| Martin, GM | 1 |
| Herr, A | 1 |
| Oshima, J | 1 |
| Martín Guerra, JM | 1 |
| Martín Asenjo, M | 1 |
| Miramontes González, JP | 1 |
| Prieto de Paula, JM | 1 |
| Afrin, LB | 1 |
| Lukina, EA | 1 |
| Sysoeva, EP | 1 |
| Kitsenko, EA | 1 |
| Varlamova, EIu | 1 |
| Inozemtseva, MV | 1 |
| Semenova, EA | 1 |
| Nadinskaia, MIu | 1 |
| Ivashkin, VT | 1 |
| Chernoff, N | 1 |
| Rogers, JM | 1 |
| Amrolia, PJ | 1 |
| Almeida, A | 1 |
| Davies, SC | 1 |
| Roberts, IA | 1 |
| Agarwal, MB | 1 |
| Stiff, T | 1 |
| Reis, C | 1 |
| Alderton, GK | 1 |
| Woodbine, L | 1 |
| O'Driscoll, M | 1 |
| Jeggo, PA | 1 |
| Bacher, U | 1 |
| Haferlach, T | 1 |
| Kern, W | 1 |
| Harich, HD | 1 |
| Schnittger, S | 1 |
| Haferlach, C | 1 |
| Fawibe, AE | 1 |
| Spry, CJ | 1 |
| Eakin, DL | 1 |
| Gill, DP | 1 |
| Weiss, GB | 1 |
| Farcet, JP | 1 |
| Binaghi, M | 1 |
| Kuentz, M | 1 |
| Merlier, JF | 1 |
| Mayaud, C | 1 |
| Nebout, T | 1 |
| Nass, P | 1 |
| Ferret, J | 1 |
| Flaum, MA | 2 |
| Schooley, RT | 2 |
| Fauci, AS | 4 |
| Gralnick, HR | 2 |
| Efira, A | 1 |
| Waterlot, Y | 1 |
| DeSimone, PA | 1 |
| Inhorn, RC | 1 |
| Aster, JC | 1 |
| Roach, SA | 1 |
| Slapak, CA | 1 |
| Soiffer, R | 1 |
| Tantravahi, R | 1 |
| Stone, RM | 1 |
| Hwang, WL | 1 |
| Gau, JP | 1 |
| Chen, MC | 1 |
| Young, JH | 1 |
| Muir, P | 1 |
| Gruffydd-Jones, TJ | 1 |
| Brown, PJ | 1 |
| Koike, M | 1 |
| Ishiyama, T | 1 |
| Cambier, N | 1 |
| Wattel, E | 1 |
| Menot, ML | 1 |
| Guerci, A | 1 |
| Chomienne, C | 1 |
| Fenaux, P | 1 |
| Chowdhury, MM | 1 |
| Patel, GK | 1 |
| Inaloz, HS | 1 |
| Holt, PJ | 1 |
| Gladwin, MT | 1 |
| Rodgers, GP | 1 |
| Chae, SW | 1 |
| Cho, JH | 1 |
| Lee, JH | 1 |
| Kang, HJ | 1 |
| Hwang, SJ | 1 |
| Parrillo, JE | 2 |
| Wolff, SM | 2 |
| Solley, GO | 1 |
| Maldonado, JE | 1 |
| Gleich, GJ | 1 |
| Giuliani, ER | 1 |
| Hoagland, HC | 1 |
| Pierre, RV | 1 |
| Brown, AL | 1 |
| Straetmans, N | 1 |
| Ferrant, A | 1 |
| Martiat, P | 1 |
| Sokal, G | 1 |
| Michaux, JL | 1 |
| Hillyer, MH | 1 |
| Mair, TS | 1 |
| Smit, AJ | 1 |
| van Essen, LH | 1 |
| de Vries, EG | 1 |
| Zielinski, RM | 1 |
| Lawrence, WD | 1 |
| Murphy, PT | 1 |
| Fennelly, DF | 1 |
| Stuart, M | 1 |
| O'Donnell, JR | 1 |
| Osterwalder, B | 1 |
| Schmid, L | 1 |
| Jungi, WF | 1 |
| Flury, R | 1 |
| Schmid, U | 1 |
| Staub, P | 1 |
| Senn, HJ | 1 |
| Shah, AM | 1 |
| Joglekar, M | 1 |
| Nadal, D | 1 |
| Plüss, HJ | 1 |
| Jörg, W | 1 |
| Hitzig, WH | 1 |
| Varon, D | 1 |
| Wetzler, M | 1 |
| Berrebi, A | 1 |
| Mercadanti, M | 1 |
| Cavalieri, F | 1 |
| Ferraccioli, GF | 1 |
| Ambanelli, U | 1 |
9 reviews available for hydroxyurea and Symptom Cluster
| Article | Year |
|---|---|
Hypoxia and the Edema Syndrome: elucidation of a mechanism of teratogenesis.
Topics: Abnormalities, Drug-Induced; Animals; Blister; Chick Embryo; Cocaine; Edema; Epinephrine; Hematoma; | 2010 |
Therapeutic challenges in childhood sickle cell disease. Part 2: a problem-orientated approach.
Topics: Anemia, Sickle Cell; Antisickling Agents; Bone Marrow Transplantation; Central Nervous System Diseas | 2003 |
Advances in management of sickle cell disease.
Topics: Acute Disease; Adolescent; Anemia, Sickle Cell; Antisickling Agents; Bacterial Infections; Blood Tra | 2003 |
Managing acute chest syndrome of sickle cell disease in an African setting.
Topics: Acute Disease; Anemia, Sickle Cell; Antisickling Agents; Diagnosis, Differential; Humans; Hydroxyure | 2008 |
The hypereosinophilic syndrome: clinical features, laboratory findings and treatment.
Topics: Anticoagulants; Bone Marrow; Central Nervous System Diseases; Endomyocardial Fibrosis; Eosinophilia; | 1982 |
A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Prot | 1995 |
[Hypereosinophilic syndrome].
Topics: Adult; Aged; Cardiovascular Diseases; Eosinophilia; Female; Humans; Hydroxyurea; Leukemia, Eosinophi | 1993 |
Sudden hearing loss in chronic myelogenous leukaemia implicating the hyperviscosity syndrome.
Topics: Blood Viscosity; Cochlea; Combined Modality Therapy; Follow-Up Studies; Hearing Loss, Sensorineural; | 2002 |
[Hypereosinophilia syndrome. Apropos of 2 cases and literature review].
Topics: Aged; Cardiomyopathy, Restrictive; Eosinophilia; Humans; Hydroxyurea; Interferon-alpha; Male; Middle | 1992 |
1 trial available for hydroxyurea and Symptom Cluster
| Article | Year |
|---|---|
All-trans retinoic acid in adult chronic myelomonocytic leukemia: results of a pilot study.
Topics: Aged; Antineoplastic Agents; Bone Marrow; Colony-Forming Units Assay; Female; Hematopoietic Stem Cel | 1996 |
28 other studies available for hydroxyurea and Symptom Cluster
| Article | Year |
|---|---|
Inactivating Mutations in Exonuclease and Polymerase Domains in DNA Polymerase Delta Alter Sensitivities to Inhibitors of dNTP Synthesis.
Topics: Base Sequence; Binding Sites; Cell Line; Deafness; Deoxyribonucleotides; DNA Polymerase III; Exonucl | 2020 |
Sclerodermiform Syndrome Induced by Hydroxycarbamide.
Topics: Humans; Hydroxyurea; Syndrome | 2021 |
Mast cell activation syndrome as a significant comorbidity in sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Antisickling Agents; Caseins; Chromogranin A; Cohort Studies; Female; He | 2014 |
[Syndrome of extrahepatic portal hypertension and chronic abdominal ischemia in patient with subleukemic myelosis and congenital immunodeficiency].
Topics: Abdomen; Adult; Anticoagulants; Antineoplastic Agents; Chronic Disease; Female; Humans; Hydroxyurea; | 2009 |
Nbs1 is required for ATR-dependent phosphorylation events.
Topics: Animals; Ataxia Telangiectasia Mutated Proteins; Cell Cycle; Cell Cycle Proteins; Cells, Cultured; D | 2005 |
A case of chronic myeloproliferative syndrome followed by precursor T-cell acute lymphoblastic leukemia.
Topics: Cell Transformation, Neoplastic; Chromosome Aberrations; Chromosome Banding; Chromosome Painting; Di | 2007 |
Response of hypereosinophilic syndrome to 6-thioguanine and cytarabine.
Topics: Adult; Cytarabine; Eosinophilia; Heart Failure; Humans; Hydroxyurea; Male; Prednisone; Syndrome; Thi | 1982 |
A hypereosinophilic syndrome with retinal arteritis and tuberculosis.
Topics: Adult; Arteritis; Cardiomyopathies; Eosinophilia; Fluorescein Angiography; Humans; Hydroxyurea; Male | 1982 |
A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations.
Topics: Bone Marrow; Busulfan; Cyclophosphamide; Dose-Response Relationship, Drug; Eosinophilia; Eosinophils | 1981 |
A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. II. Clinical manifestations.
Topics: Adolescent; Adult; Aged; Child; Cyclophosphamide; Eosinophilia; Heart Diseases; Humans; Hydroxyurea; | 1981 |
[Hypereosinophilia (author's transl)].
Topics: Adult; Electrocardiography; Eosinophilia; Female; Hemiplegia; Humans; Hydroxyurea; Male; Middle Aged | 1981 |
Grand rounds. Hypereosinophilic syndrome: a review of clinical manifestations and therapy.
Topics: Adrenal Cortex Hormones; Eosinophilia; Humans; Hydroxyurea; Syndrome | 1980 |
Treatment of acute promyelocytic leukemia with all-trans retinoic acid: successful control of hyperleukocytosis and leukostasis syndrome with leukaphereses and hydroxyurea.
Topics: Administration, Oral; Adult; Female; Humans; Hydroxyurea; Leukapheresis; Leukemia, Promyelocytic, Ac | 1993 |
Hypereosinophilic syndrome in a cat.
Topics: Animals; Cat Diseases; Cats; Eosinophilia; Eosinophils; Hydroxyurea; Lymph Nodes; Lymphatic Diseases | 1993 |
Hydroxyurea-induced skin disease mimicking the baboon syndrome.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Drug Eruptions; Enzyme Inhibitors; Exanthema; Fema | 1999 |
Pathogenesis and treatment of acute chest syndrome of sickle-cell anaemia.
Topics: Adult; Anemia, Sickle Cell; Antisickling Agents; Blood Transfusion; Humans; Hydroxyurea; Nitric Oxid | 2000 |
The hypereosinophilic syndrome: dramatic response to therapeutic intervention.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Eosinophilia; Female; Humans; Hydroxyurea; Male; M | 1977 |
Therapy of the hypereosinophilic syndrome.
Topics: Adolescent; Adult; Aged; Bone Marrow Diseases; Child; Child, Preschool; Eosinophilia; Female; Humans | 1978 |
Endomyocardiopathy with eosinophilia.
Topics: Adolescent; Adult; Busulfan; Cardiomyopathies; Cytoplasmic Granules; Digoxin; Diphenhydramine; Eosin | 1976 |
Multisystemic eosinophilic epitheliotropic disease in a horse: attempted treatment with hydroxyurea and dexamethasone.
Topics: Animals; Dexamethasone; Eosinophilia; Epithelium; Female; Gastrointestinal Diseases; Horse Diseases; | 1992 |
Successful long-term control of idiopathic hypereosinophilic syndrome with etoposide.
Topics: Adult; Cardiomegaly; Eosinophilia; Etoposide; Humans; Hydroxyurea; Male; Syndrome; Thrombocytopenia | 1991 |
Interferon-alpha for the hypereosinophilic syndrome.
Topics: Adult; Eosinophilia; Humans; Hydroxyurea; Interferon Type I; Leukocyte Count; Male; Prednisone; Synd | 1990 |
Alfa-interferon in a case of hypereosinophilic syndrome.
Topics: Adult; Eosinophilia; Humans; Hydroxyurea; Interferon alpha-2; Interferon-alpha; Male; Prednisolone; | 1990 |
[Myeloproliferative syndrome and acute febrile neutrophilic dermatosis (Sweet's syndrome)--a rare association].
Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Fever; Humans; Hydroxyurea; Male; Myeloproliferative D | 1987 |
Eosinophilic colitis as a complication of the hypereosinophilic syndrome.
Topics: Adult; Colitis; Eosinophilia; Female; Humans; Hydroxyurea; Syndrome | 1987 |
[Hypereosinophilic syndrome in acute lymphatic leukemia].
Topics: Child, Preschool; Diagnosis, Differential; Eosinophilia; Humans; Hydroxyurea; Leukemia, Lymphoid; Ma | 1986 |
Hypereosinophilic syndrome associated with polycythemia vera.
Topics: Eosinophilia; Female; Humans; Hydroxyurea; Middle Aged; Polycythemia Vera; Primary Myelofibrosis; Re | 1986 |
[Idiopathic hypereosinophilic syndrome. Current clinico-therapeutic state].
Topics: Adrenal Cortex Hormones; Adult; Antibody Formation; Anticoagulants; Blood Proteins; Cardiomyopathies | 1985 |